Fig. 3From: Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the ratRelative changes in CGRP, SP and SOM release in vehicle-treated animals and in animals 7 days after treatment with galcanezumab. CGRP and SP content was measured in the same sample after stimulating the dura mater with capsaicin at 100 nM, while release of SOM was induced with KCl at 60 mM. The number of experiments is indicated in the bars. *: p < 0.05Back to article page